Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
73,943,049
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
49,033,906
-
Shares change
-
+8,294,123
-
Total reported value, excl. options
-
$653,981,856
-
Value change
-
+$116,531,831
-
Put/Call ratio
-
53.89%
-
Number of buys
-
84
-
Number of sells
-
-41
-
Price
-
$13.35
Significant Holders of Perspective Therapeutics, Inc. - COMMON STOCK (CATX) as of Q3 2024
147 filings reported holding CATX - Perspective Therapeutics, Inc. - COMMON STOCK as of Q3 2024.
Perspective Therapeutics, Inc. - COMMON STOCK (CATX) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49,033,906 shares
of 73,943,049 outstanding shares and own 66.31% of the company stock.
Largest 10 shareholders include FMR LLC (5,504,822 shares), JANUS HENDERSON GROUP PLC (4,799,352 shares), BlackRock, Inc. (4,039,974 shares), Avidity Partners Management LP (3,444,002 shares), COMMODORE CAPITAL LP (3,350,000 shares), VANGUARD GROUP INC (3,076,941 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,817,763 shares), STATE STREET CORP (2,190,239 shares), Nicholson Wealth Management Group, LLC (1,602,283 shares), and MARSHALL WACE, LLP (1,490,791 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.